Last update 16 Mar 2026

111In-IPN01087

Overview

Basic Info

Drug Type
Small molecule drug, Diagnostic radiopharmaceuticals
Synonyms-
Target
NTSR1
Action
antagonists
Mechanism
NTSR1 antagonists(Neurotensin receptor 1 antagonists)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease
Active Indication-
Inactive Indication
Colorectal CancerMetastatic Pancreatic Ductal Adenocarcinoma
Originator Organization
Ipsen SAIpsen SA
Active Organization-
Inactive Organization
Ipsen SAIpsen SA
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with 111In-IPN01087
NCT04632199
/ WithdrawnPhase 1
A Phase I, Open Label, Study to Assess Safety, Tolerability, Biodistribution, Radiation Dosimetry and SPECT/CT Imaging Characteristics of Intravenous 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma or Colorectal Cancer.
100 Clinical Results associated with 111In-IPN01087
Login to view more data
100 Translational Medicine associated with 111In-IPN01087
Login to view more data
100 Patents (Medical) associated with 111In-IPN01087
Login to view more data
100 Deals associated with 111In-IPN01087
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPhase 1
Belgium
Ipsen SAIpsen SA
12 Mar 2021
Colorectal CancerPhase 1
France
Ipsen SAIpsen SA
12 Mar 2021
Metastatic Pancreatic Ductal AdenocarcinomaPhase 1
Belgium
Ipsen SAIpsen SA
12 Mar 2021
Metastatic Pancreatic Ductal AdenocarcinomaPhase 1
France
Ipsen SAIpsen SA
12 Mar 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free